- Home
- WYNN vs EXAS Comparison
WYNN vs EXAS Comparison
Compare WYNN & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYNN
- EXAS
- Stock Information
- Founded
- WYNN 2002
- EXAS 1995
- Country
- WYNN United States
- EXAS United States
- Employees
- WYNN N/A
- EXAS N/A
- Industry
- WYNN Hotels/Resorts
- EXAS Medical Specialities
- Sector
- WYNN Consumer Discretionary
- EXAS Health Care
- Exchange
- WYNN Nasdaq
- EXAS Nasdaq
- Market Cap
- WYNN 11.6B
- EXAS 10.2B
- IPO Year
- WYNN 2002
- EXAS N/A
- Fundamental
- Price
- WYNN $123.28
- EXAS $52.38
- Analyst Decision
- WYNN Strong Buy
- EXAS Strong Buy
- Analyst Count
- WYNN 14
- EXAS 22
- Target Price
- WYNN $125.57
- EXAS $67.38
- AVG Volume (30 Days)
- WYNN 1.9M
- EXAS 2.8M
- Earning Date
- WYNN 11-03-2025
- EXAS 11-04-2025
- Dividend Yield
- WYNN 0.81%
- EXAS N/A
- EPS Growth
- WYNN N/A
- EXAS N/A
- EPS
- WYNN 3.40
- EXAS N/A
- Revenue
- WYNN $6,970,314,000.00
- EXAS $2,939,949,000.00
- Revenue This Year
- WYNN $0.45
- EXAS $16.68
- Revenue Next Year
- WYNN $4.08
- EXAS $12.08
- P/E Ratio
- WYNN $36.29
- EXAS N/A
- Revenue Growth
- WYNN N/A
- EXAS 12.55
- 52 Week Low
- WYNN $65.25
- EXAS $38.81
- 52 Week High
- WYNN $128.53
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- WYNN 59.79
- EXAS 56.95
- Support Level
- WYNN $119.72
- EXAS $46.30
- Resistance Level
- WYNN $124.38
- EXAS $56.52
- Average True Range (ATR)
- WYNN 3.14
- EXAS 1.67
- MACD
- WYNN -0.59
- EXAS 0.26
- Stochastic Oscillator
- WYNN 40.41
- EXAS 59.49
About WYNN Wynn Resorts Limited Common stock
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.